KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to -$0.13.

  • Pacific Biosciences Of California's EPS (Basic) rose 4090.91% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.69, marking a year-over-year decrease of 1575.34%. This contributed to the annual value of -$1.13 for FY2024, which is 670.81% up from last year.
  • As of Q3 2025, Pacific Biosciences Of California's EPS (Basic) stood at -$0.13, which was up 4090.91% from -$0.14 recorded in Q2 2025.
  • Pacific Biosciences Of California's 5-year EPS (Basic) high stood at $0.08 for Q3 2021, and its period low was -$1.44 during Q1 2025.
  • Moreover, its 5-year median value for EPS (Basic) was -$0.31 (2023), whereas its average is -$0.34.
  • Over the last 5 years, Pacific Biosciences Of California's EPS (Basic) had its largest YoY gain of 15714.29% in 2021, and its largest YoY loss of 460000.0% in 2021.
  • Pacific Biosciences Of California's EPS (Basic) (Quarter) stood at -$0.33 in 2021, then dropped by 12.12% to -$0.37 in 2022, then rose by 16.22% to -$0.31 in 2023, then skyrocketed by 102.79% to $0.01 in 2024, then tumbled by 1605.0% to -$0.13 in 2025.
  • Its EPS (Basic) was -$0.13 in Q3 2025, compared to -$0.14 in Q2 2025 and -$1.44 in Q1 2025.